Text and Data Mining valid from 2016-04-04
Received: 11 January 2016
Accepted: 13 January 2016
First Online: 4 April 2016
: Following completion of studies conducted at MSKCC that are summarized in this review, Atara Biotherapeutics licensed the MSKCC banks of EBV and CMV-specific T-cell lines. As a result, Richard J O’Reilly, Aisha N Hasan, Ekaterina Doubrovina and Guenther Koehne have received royalties from Atara Biotherapeutics. Ekaterina Doubrovina has also received consulting fees from Atara Biotherapeutics.